Holen Sie sich die Stockscreener-App
23.55
4.53%
1.02
Handel nachbörslich:
23.47
-0.08
-0.34%
Schlusskurs vom Vortag:
$22.53
Offen:
$22.37
24-Stunden-Volumen:
66,734
Relative Volume:
1.38
Marktkapitalisierung:
$1.05B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-7.50%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$22.37
$24.09
1-Wochen-Bereich:
$21.45
$25.99
52-Wochen-Spanne:
$18.62
$26.34
Septerna Inc Stock (SEPN) Company Profile
Vergleichen Sie SEPN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| SEPN | 23.55 | 1.05B | 0 | 0 | 0 | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Septerna Inc Aktie (SEPN) Neueste Nachrichten
RA Capital Management's Strategic Investment in Septerna Inc - GuruFocus.com
Buffett Still Building This Stake, Plus Huge Insider Buy in Biotech IPO - 24/7 Wall St.
Wednesday's Insider Activity: Top Buys and Sells in US Stocks By Investing.com - Investing.com Australia
Nasdaq debutante Septerna swells its IPO to $331m - pharmaphorum
Septerna (NASDAQ:SEPN) Files Amendment and Restatement of Certificate of Incorporation and Bylaws - Defense World
Ra Capital Management buys $75 million in Septerna stock - Investing.com India
Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering - ForexTV.com
Ra Capital Management buys $75 million in Septerna stock By Investing.com - Investing.com Australia
IPO Radar: Septerna, Swiggy and Horizon Robotics - The Armchair Trader
Septerna sees $11.7 million in stock purchases by Third Rock Ventures - Investing.com South Africa
IPO Roundup: Brazil Potash, Septerna and more (NYSEARCA:IPO) - Seeking Alpha
Septerna proposes terms for upsized $175M IPO - MSN
U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names - Seeking Alpha
Septerna’s GPCRs draw strong demand in $288M IPO - BioCentury
Finance Watch: Septerna Raises $288m In Public Market Debut - Citeline
Hedge Funds, Asset Managers Turn Dollar Bulls on Election Risks - Yahoo Finance
Septerna Shares Jump 19% After IPO Shows Biotech Still Hot - Bloomberg
Septerna Shares Rise 29% on First Trading Day - MarketWatch
Septerna’s Upsized IPO Brings In $288M to Support a Pipeline of GPCR Drugs - MedCity News
Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut - KFGO
Septerna Shares Jump 42% After IPO Shows Biotech Still Hot - AllSides
Goodwin, Cooley Guide Septerna's Upsized $288M IPO - Law360
Septerna's $288M IPO is another sign of the market warming to biotech investment - Fierce Biotech
Septerna Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Septerna Rings the Opening Bell - Nasdaq
MicroStrategy Touches New Highs as Trading Volume Relative to Nvidia Surges - Yahoo Finance
Septerna Prices Upsized 16M Share IPO at $18/sh By Investing.com - Investing.com Nigeria
Septerna Prices Upsized 16M Share IPO at $18/sh - Investing.com
Septerna Shares Set for Trading Debut After Upsized IPO - MarketWatch
Goldman-backed drug developer Septerna raises $288mln in US IPO - ZAWYA
GPCR drugmaker Septerna amasses $288M in IPO - BioPharma Dive
Goldman-backed drug developer Septerna raises $288 mln in US IPO - Reuters
Septerna Prices Upsized Initial Public Offering - The Manila Times
SEPNSepterna, Inc. Latest Stock News & Market Updates - StockTitan
TSX Smallcap Index (TXTW) QuotePress Release - The Globe and Mail
S&P Midcap 400 (IDX) QuotePress Release - The Globe and Mail
Yorvipath-finders? Septerna, others forge on in hypothyroidism - BioWorld Online
Goldman-backed drug developer Septerna targets $743 million valuation in upsized US IPO - MSN
Septerna Files for 15.28M Share IPO at $18/sh By Investing.com - Investing.com Canada
Goldman-backed drug developer Septerna targets $743 mln valuation in upsized US IPO - XM
7 Recent and Upcoming IPOs in 2024 - MSN
Septerna Files for 15.28M Share IPO at $18/sh - Investing.com India
TSX 60 Carbon Price Risk 2030 Adj Index (TXCP) QuotePress Release - The Globe and Mail
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
Septerna proposes terms for upsized $175M IPO (Pending:SEPN) - Seeking Alpha
Septerna Readies $175 Million IPO Plan For Endocrine And Immune Disease Treatments (Pending:SEPN) - Seeking Alpha
The Preclinical IPO Comeback Continues With Septerna’s $158m Goal - Citeline
TSX 60 ESG Index (TSXE) QuotePress Release - The Globe and Mail
Finanzdaten der Septerna Inc-Aktie (SEPN)
Es liegen keine Finanzdaten für Septerna Inc (SEPN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):